22 July 2020
Latham & Watkins Advises Kiniksa Pharmaceuticals, Ltd. in Upsized Public Offering
Advising firms
Deal team
4 lawyers named| Lawyer | Firm | Seniority | Practice | Office |
|---|---|---|---|---|
| Nathan Ajiashvili Lead | Latham & Watkins LLP | Partner | capital markets | New York |
| Jennifer Yoon | Latham & Watkins LLP | Associate | capital markets | Not stated |
| Andrew Weitzel | Latham & Watkins LLP | Associate | capital markets | Not stated |
| Emily Henderson | Latham & Watkins LLP | Associate | capital markets | Not stated |
1 more lawyer on this deal. Register free to see the full deal team, with seniority, practice and office.
REGISTER FREE SIGN INWant co-counsel patterns, repeat clients and alerts when these firms land their next deal? Get Pro.
Stated terms
- Stated value
- USD 155m (approximately US$155 million)
- What the figure measures
- Total transaction value
- Client
- Kinikska Pharmaceuticals, Ltd.Issuer
- Counterparties
- Not stated